RA-9
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-136528-50 mg |
| CAS # | 919091-63-7 |
| Pricing | 50 mg, USD $240.0 |
| Biological Activity | RA-9 is a potent and selective proteasome-associated deubiquitinating enzymes (DUBs) inhibitor with favorable toxicity profile and anticancer activity. RA-9 blocks ubiquitin-dependent protein degradation without impacting 20S proteasome proteolytic activity. RA-9 selectively induces onset of apoptosis in ovarian cancer cell lines and primary cultures derived from donors. RA-9 induces endoplasmic reticulum (ER)-stress responses in ovarian cancer cells[1]. |
| Purity | 98.12% |
| MWt | 365.34 |
| Formula | C₁₉H₁₅N₃O₅ |